Med. praxi. 2011;8(2):77-82

Current trends in treatment of vulvovaginal discomfort

doc.MUDr.Jiří ©paček, Ph.D., IFEPAG1, doc.RNDr.Vladimír Buchta, CSc.2, PharmDr.Petr Jílek, CSc.3, MUDr.Petr Halada1, MUDr.Jan Kestřánek1
1 Porodnická a gynekologická klinika, LF a FN v Hradci Králové
2 Ústav klinické mikrobiologie, LF a FN v Hradci Králové
3 Katedra biologických a lékařských věd, Farmaceutická fakulta UK v Hradci Králové

The most common causes of acute vulvovaginal discomfort are vulvovaginal candidiasis and bacterial vaginosis. While in sporadic cases

of acute vulvovaginal candidiasis one-time anti-infective treatment is highly effective, in chronic vulvovaginal discomfort it tends to

have a transient effect only. In the long-term perspective, it is advisable to rather improve the quality of the vaginal milieu in the case of

chronic conditions. A wide range of supportive products are available. The vagina and vulva are strongly estrogen-dependent; therefore,

hormonal intervention may also be an option.

Keywords: vulvovaginal discomfort, disturbance in the vaginal milieu, vulvovaginal candidiasis, bacterial vaginosis

Published: February 22, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©paček IFEPAG J, Buchta V, Jílek P, Halada P, Kestřánek J. Current trends in treatment of vulvovaginal discomfort. Med. praxi. 2011;8(2):77-82.
Download citation

References

  1. Berg AO, Heidrich FE, Fihn SD, et al. Establishing the cause of genitourinary symptoms in women in a family practice. JAMA, 1984; 251: 620-625. Go to original source...
  2. Kent HL. Epidemiology of vaginitis. Am. J. Obstet. Gynecol. 1991; 165: 1168-1176. Go to original source... Go to PubMed...
  3. ©paček J, Buchta V. Itraconazole in the treatment of acute and recurrent vaginal candidosis: Comparison of the therapeutic effectiveness and occurrence of relapses in one-day and three-day regimens. Mycoses, 2005; 48: 165-171. Go to original source... Go to PubMed...
  4. Donders GGG, Verecken A, Bosmans E, et al. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG: Int. J. Obst. Gynaecol. 2002; 109: 34-43. Go to original source... Go to PubMed...
  5. ©paček J, Buchta V, Veselský Z, et al. Interakce kvasinek s hostitelem ve vztahu k urogenitálnímu traktu, vulvovaginální kandidóza, urologické aspekty mykotických onemocnění. Čs. Gynekol. 2003; 68: 432-439.
  6. ©paček J, Buchta V, Jílek P, et al. Clinical aspects and luteal phase assessment in patients with recurrent vulvovaginal candidiasis. Eur. J. Obst. Gyn. Repr. Biol. 2007; 131: 198-202. Go to original source... Go to PubMed...
  7. ©paček J, Buchta V, Jílek P, et al. What does it mean the diagnosis of recurrent vulvovaginal candidiasis? 9th World Congress for Infectious and Immunological Diseases in Obstetrics and Gynaecology, Urology and Dermatology, November 19-26, 2005, Maceio, Brazil, Book of Abstratcs (62).
  8. Förstl M, ©paček J, Buchta V, et al. Diferenciální diagnostika zánětů pochvy a zevního genitálu, moľnosti a limity mikrobiologického vyąetření. Čs. gynekol, 2005; 70: 79-86. Go to original source...
  9. Buchta V, ©paček J, Jílek P. Mykotické infekce ľenského genitálu III. Terapie. Gynekolog. 1998; 7: 73-82.
  10. Tempera G, Abbadessa G, Bonfiglio G, Cammarata E, Cianci A, Corsello S, Raimondi A, Ettore G, Nicolosi D, Furneri PM. Topical kanamycin: an effective therapeutic option in aerobic vaginitis. J. Chemother. 2006; 18: 409414. Go to original source... Go to PubMed...
  11. Mastromarino P, Macchia S, Meggiorini L, Trinchieri V, Mosca L, Perluigi M, Midulla C. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin. Microbiol. Infect. 2009; 15: 67-74. Go to original source... Go to PubMed...
  12. Buchta V, Slezák R, ©paček J, Koą»álová M, Vejsová M, Doleľal M. Současné moľnosti léčby koľních a slizničních mykóz. Med Pro Praxi, 2009; 6: 155-164.
  13. Sobel J, Nagappan V, Nyirjesy P. Metronidazole-resistant vaginal trichomoniasis: an emerging problem. N. Engl. J. Med. 1999; 341: 292-293. Go to original source... Go to PubMed...
  14. Poppe WAJ. Nitroimidazole resistant vaginal trichomoniasis treated with paromomycin. Eur. J. Obstet. Gynecol. Reprod. Biol. 2001; 96: 119-120. Go to original source... Go to PubMed...
  15. DuBouchet L, Spence MR, Rein MF, Danzig MR, McCormack WM. Multicenter comparison of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine hydrochloride, and allantoin in the treatment of symptomatic trichomoniasis. Sex. Transm. Dis. 1997; 24: 156-160. Go to original source... Go to PubMed...
  16. Klebanoff MA, Carey JC, Hauth JC, Hillier SL, Nugent RP, Thom EA, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N. Eng. J. Med. 2001; 345: 487-493. Go to original source... Go to PubMed...
  17. Maąata J, Jedličková A, et al. Infekce v gynekologii. Praha: Maxdorf 2006; 36-44, 57-60.
  18. Witkin SS, Linhares IM, Giraldo P. Bacterial flora of the female genital tract: function and immune regulation. Best Pract. Res. Clin. Obstet. Gynaecol. 2007; 21: 347-354. Go to original source... Go to PubMed...
  19. Reid G, Bruce AW. Probiotics to prevent urinary tract infections: the rationale and evidence. World J. Urol. 2006; 24: 28-32. Go to original source... Go to PubMed...
  20. Lee Y. Characterization of Weissella kimchii PL9023 as a potential probiotic for women. FEMS Microbiol. Lett. 2005; 250: 157-162. Go to original source... Go to PubMed...
  21. Cianci A, Giordano R, et al. Efficacy of Lactobacillus Rhamnosus GR-1 and of Lactobacillus Reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses. Minerva Ginecol. 2008; 60: 369-376. Go to PubMed...
  22. Marcone VE, Calzolari, et al. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences. New Microbiologica 2008; 31: 429-433. Go to PubMed...
  23. Martinez RCR, Franceschini SA, et al. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Canad. J. Microbiol. 2009; 55: 133-138. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.